CompletedNot Applicable

Clinical Value of the MRI Combined With SCC-Ag for the Diagnosis of HSIL (CIN 2/3)

China186 participantsStarted 2021-03-01

Plain-language summary

The study aimed to identify the clinical value of Magnetic Resonance Imaging examination (MRI)combined with serum squamous cells carcinoma antigen (SCC-Ag) in women with high-grade squamous intraepithelial lesion (cervical intraepithelial neoplasia grades 2-3 (CIN 2-3)).

Who can participate

Age range26 Years – 82 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * No previous history of cervical lesions * TCT and HPV test results suspected cervical lesions * Further colposcopy showed HSIL or CIN 2-3 * All selected patients underwent MRI, serological tests for SCC-Ag levels, LEEP, or radical hysterectomy Exclusion Criteria: * Patients with receiving cold knife conization * Patients with skin squamous cell carcinoma or previous history of cancer * Pregnant women * Patients with serious heart, liver, kidney, blood system and autoimmune diseases

What they're measuring

The number of cases whose combined diagnosis of MRI and SCC Ag In postmenopausal women

Timeframe: 20 days

the number of cases whose combined diagnosis of MRI and SCC Ag for the non-menopausal group.

Timeframe: 20 days

Trial details

NCT IDNCT05487209

SponsorSecond Affiliated Hospital of Wenzhou Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-01

View on ClinicalTrials.gov More Magnetic Resonance Imaging Examination trials